Higher fiber intake reduced all-cause and cardiovascular mortality among healthy population, but such data in dialysis patients are limited. We aimed to examine these associations in patients on peritoneal dialysis. This single-center prospective cohort study enrolled 881 incident PD patients between October 2002 and August 2014. All patients were followed until death, transfer to hemodialysis, renal transplantation or until being censored in June 2018. Demographic data were collected at baseline. Biochemical, dietary, and nutrition data were examined at baseline and thereafter at regular intervals to calculate the average values throughout the study. The outcomes were defined as all-cause and cardiovascular death. Cox proportional regression models were applied to explore the relationship between fiber intake and outcomes. Participants with higher fiber intake were more likely to be younger, male, and having better residual renal function and serum lipids at baseline. They were prone to maintain better nutrient status, higher blood pressure and lower inflammatory status at baseline and afterward. Neither baseline nor time-averaged fiber intake did show protective effects on all-cause mortality after multivariate adjustment in the whole cohort. Among non-diabetic PD patients, an independent association between fiber intake and all-cause mortality was found, in which each 1g/day of increase in time-averaged fiber intake correlated to 13% of reduction in all-cause mortality. We did not observe any benefits of fiber intake in the CVD mortality for both whole cohort and subgroups. This study revealed that higher dietary fiber intake appeared to have a protective effect on all-cause mortality in non-diabetic PD patients, which suggest that PD patients should be encouraged to eat a diet rich in fibers.
Introduction
In the general population, considerable epidemiological evidences have proven that dietary fiber is related to the decreased risk for various chronic diseases such as cardiovascular disease (CVD), type 2 diabetes, hypertension, major cancer (1) , and chronic kidney disease (CKD) (2-6). A higher fiber intake is also independently associated with all-cause and CVD mortality in the general population, and among patients with CVD, diabetes mellitus (DM), and cancer, as shown from prospective cohort studies and meta-analysis (7-9).
For patients with CKD, the predictive role of dietary fiber in mortality has been reported from the ULSAM (10) and NHANES III cohorts (11). There are still limited data on the relationship between dietary fiber and mortality in dialysis population, despite that recent observational studies indicated that fiber supplementation could improve the lipid profile and oxidative status, and decrease the systemic inflammatory state in patients on dialysis (12, 13). The current guidelines also make little or no reference to dietary fiber intake for patients with CKD due to the lack of evidence (14) (15) (16) . Recently, a meta-analysis in CKD assessed the benefits of whole dietary pattern in the decreased risk for mortality rather than the nutrient components of the diet (17) . A so-called healthy dietary pattern, enriched with fruit and vegetables, fish, legumes, cereals, whole grains, and fiber, cannot recommend the target for a specific nutrient to meet patients' needs.
Therefore, in the present study, we aimed to evaluate the associations between dietary fiber intake measured at baseline or in a time-averaged manner, and all-cause and CVD mortality through a prospective peritoneal dialysis cohort. The prognostic value of dietary fiber would be also explored among patients categorized by CVD or non-CVD, DM or non-DM respectively.
Subjects and Methods

Subjects and follow-up
This is a prospective cohort with data retrospectively analyzed, carried out at the PD center of Peking University First Hospital. All incident PD patients between October 1, 2002 , and August 31, 2014, were screened. Patients were excluded if they refused to complete the baseline test, denied the diagnosis of end-stage renal disease or could not be regularly followed. All patients were followed until death, transfer to hemodialysis (HD), renal transplantation, loss to follow-up or June 30, 2018 (the end of study). All patients were treated with continuous ambulatory peritoneal dialysis and visited a physician at least once every 3 months. All patients began the PD program within 1 month after catheter implantation and were given lactate-buffered glucose dialysate with a twin-bag connection system (Baxter Healthcare, Guangzhou, China). This study was approved by the Medical Ethics Committee of Peking University. Written informed consent was obtained from each patient.
Data collection
Demographic and clinical data including age, gender, body mass index (BMI), the presence of CVD and DM were collected within the week preceding PD catheter implantation. Baseline values included all measurements of blood pressure, biochemistry, dialysis adequacy, dietary and nutrition parameters in the first 3 months. Baseline values of dietary nutrients were calculated in the first 6 months. All the above measurements during the study period were prospectively collected and averaged for each 6-month interval to calculate time-averaged values.
Dietary variables
During the follow-up, patients completed 3-day dietary records before they visited the dietitian. A dedicated dietitian checked the diary by using food models. The dietary records would be invalid if they were recorded in less than 3 days or did not get checked successfully by the dietitian. Food models were used to estimate actual amounts of foods recorded in the diet diary. Daily fiber, protein, energy, carbohydrate, and fat were calculated by using a computer software program (PD information Management System, Peritoneal Dialysis Center, Peking University, Beijing, China). Oral nutrition supplements including nutritionally complete food product such as Ensure and nutritionally incomplete food product such as protein powder were also recorded to calculate the total amount of protein and energy intake. The daily energy intake includes intakes from dietary and dialysate sources.
Biochemical, Dialysis Adequacy, and Nutrition Variables
Biochemistry data including hemoglobin (Hb), serum albumin (Alb), lipids spectrum, glucose, uric, urea, creatinine, calcium, phosphate, intact parathyroid hormone (iPTH) and so on were examined using an automatic Hitachi chemistry analyzer (Hitachi Chemical, Tokyo, Japan). Serum high-sensitive C-reactive protein (hs-CRP) was measured by immune rate nephelometric analysis. Dialysis adequacy, residual renal function (RRF), and glucose absorption were measured by collecting 24-hour urine and dialysate. Dialysis adequacy was defined as total urea clearance and total creatinine clearance. RRF was estimated using the average renal clearance of urea and creatinine. Glucose absorption via dialysate was calculated by subtracting glucose amounts in drained dialysate from that in instilled dialysate, expressed as grams of glucose/day, and then dialysate energy absorption was calculated as kcal of energy/day.
Definition of outcome event
The outcomes were defined as cardiovascular and all-cause death. The cardiovascular death was defined as death due to myocardial infarction, congestive heart failure, cerebral bleeding, cerebral infarction, arrhythmia, peripheral arterial disease, and sudden death (18) .
In all analysis, we censored follow-up at transferring to HD, renal transplantation, loss to follow-up, or the end of the study (June 30, 2018) .
Statistical analysis
The mortality rate in peritoneal dialysis cohorts over an average follow-up of 45 months was estimated as 40% based on our researches before (19, 20) . The standard deviation of fiber intake in hemodialysis patients was 5g/day (21, 22) and the expected hazard radio of fiber intake in PD patients was estimated to be 0.95(11) according to previous researches. We estimated that with a sample of 421 participants, the study would have 90% statistical power at a significance level of 0.05 for a 2-sided test. In order to achieve the greatest statistical power, we included all individuals in the cohort. Statistical analyses were performed using the SPSS software package version 24.0 (SPSS, Chicago, IL, USA). Parametric data are presented as mean ± standard deviation. Nonparametric data are presented as median values with an inter-quartile range (IQR). Categorical variables are expressed as percentages or ratios. Baseline fiber intake and time-averaged fiber intake was categorized by tertile based on the distribution among the study population. One-way ANOVA, Kruskal Wallis, or the Χ 2 test was used to compare the differences of variables between groups. Differences in the survival curves between the three groups were evaluated using the log rank test. Changes in blood pressure, renal function, and laboratory data over time were also compared among groups using a mixed model analysis of variance, with bootstrap covariance accounting for correlated measures within a subject adjusted baseline characteristics, age, gender, and BMI. Recognized confounders combined with the baseline and time-averaged fiber intakes, respectively, were evaluated by the Cox proportional regression model to determine the risk for CVD and all-cause mortality. When the baseline fiber intake was examined, the covariates included age, gender, BMI, baseline mean arterial pressure (MAP), Alb, Hb, hs-CRP, triglycerides, iPTH, RRF, total protein intake and total energy intake; when the time-averaged fiber intake was examined, the covariates included age, gender, time-averaged BMI, MAP, Alb, Hb, hs-CRP, triglycerides, iPTH, RRF, total protein intake, and total energy intake. We reported the multivariable-adjusted hazard ratios (HRs) with 95% confidence intervals. The calculation of time-averaged biochemistry, nutrition and dialysis parameters in the models used the half-yearly measurements. And we chose the 3-year period of observation here to calculate the total time-averaged values. All statistical tests were two-tailed, and the significance level was set at P < 0.05. 
Subject demographics and follow-up
We followed 881 incident PD patients (434 men, 447 women), mean age of 57.7±14.8 years for 45.0(21.5, 74.0) months; 42.1% had DM, and CVD was present in 42.6% (Table 1) .
At the end of the study, 151 patients were still being maintained on PD, 434 had died, 164 had transferred to HD, 114 had undergone renal transplantation, and 18 had lost to follow-up. A total of 178 of 434 (41.0%) of all deaths were due to cardiovascular causes, and 107 of 434 (24.7%) were due to infection (Table 2 ). According to the time-averaged fiber intake, patients in the lower tertile had a much shorter follow-up time and higher mortality rate (P<0.001). Along with an increased intake of fiber, patients were less prone to be transferred to HD due to socioeconomic causes and more likely to receive the renal transplantation. The main characteristics of ceased and alive patients were present in Table 2 .
Dietary fiber intake and clinical characteristics at baseline
The baseline fiber intake was 8.2±3.4g/day in our cohort. The baseline characteristics of the study population tertiled by baseline fiber intake were given in Table 1 . There were significant differences in age, gender, BMI, the prevalence of CVD, diastolic blood pressure (DBP) and MAP, Alb, Hb, Hs-CRP, urea nitrogen, potassium, sodium, total cholesterol, triglycerides, iPTH, RRF, total creatinine clearance, dietary nutrients including energy, protein, carbohydrate, fat, fiber, normalized daily protein and energy intake levels between groups (P<0.001, 0.01 or 0.05). Patients in the middle or/and high tertile were more likely to be male, younger, having higher BMI and low prevalence of CVD than those in the low tertile. The levels of DBP, MAP, Alb, Hb, potassium sodium, iPTH and all dietary nutrients in the middle or/and high tertile were also significantly higher than those in the low tertile. In addition, patients in the middle or/and high tertile had better RRF and serum lipid spectrum, and lower inflammation level.
Dietary fiber intake and the change trend of blood pressure and biochemistry data during follow-up
The change trend of blood pressure and all laboratory measurements were explored according to the tertile of time-averaged dietary fiber intake, adjusted for age, gender and BMI. The trends of DBP, serum Alb, Hb and Hs-CRP were significantly different between tertiles (P<0.001). The high or/and middle fiber intake group had increased DBP values than low fiber intake group during the first 24-month, or increased Hb values during the first 12-month observation period (P<0.05) (Figure 2-2, 3 ). The serum Alb values were increasing along with the increased intake of fiber at each time point during the whole period (P<0.05) (Figure 2-4) . Besides, hs-CRP values in low fiber intake group were significantly higher than those in the high fiber intake group during the whole period, also were higher than those in the middle group after 6 months (P<0.05). (Figure  2-6 ).
There were no differences in the change trend of SBP, RRF, triglyceride and cholesterol between groups (Figure 2-1, 5, 7, 8) . Also, other laboratory measurements such as serum calcium, phosphorus, potassium, sodium and iPTH did not show significant differences during the follow up between groups (data not shown). respectively. By multivariate Cox regression analysis, with an increase of 1g/day in baseline and time-averaged dietary fiber intake, all-cause mortality showed a trend to decrease by 4% (P=0.053) and 6% (P=0.065) respectively, no achieving significant differences after multivariate adjustment. For subgroups analyzes, an increase of 1g/day in time-averaged fiber intake was significantly associated with a decrease of 13% in all-cause mortality HR [0.87 (0.76, 0.98), P=0.022] among non-diabetic patients (Table 3 ).
When our subjects were categorized by baseline or time-averaged dietary fiber, we did not find that high tertile group show any protective effects on the all-cause mortality than low tertile group. A trend of benefits for high tertile of fiber intake in all-cause mortality were found among patients without CVD, but no achieving significant differences.
As for CVD mortality, only baseline fiber intake showed a protective effect, with HR [0.94 (0.89, 0.99), P=0.019] in the unadjusted analysis. By multivariate Cox regression analysis, there were no obvious associations between dietary fiber intake as continuous or categorical variables and CVD mortality, either in the whole cohort, or in any subgroups (Table 4) .
Discussion
In this long-term prospective cohort study, participants with higher fiber intake were more likely to be younger and male. They tended to have better nutritional status, higher blood pressure, and lower inflammatory status at baseline and afterwards. Both baseline and time-averaged fiber intake showed protective effects against all-cause mortality by univariate analysis. Despite that this benefit was weakened after multivariate adjustment for the whole cohort, an independent association between fiber intake and all-cause mortality was still found among non-diabetic patients on PD.
An inverse association between dietary fiber intake and all-cause mortality is considered plausible. Some clinical clues should be recognized from the present study. Patients with higher fiber intake were likely to eat more foods enriched with all dietary nutrients, and thus maintain high values of serum Alb and Hb during the study period. Since serum Alb is significantly predictive of clinical outcomes (23) , an increase of approximate 2 g/L in serum Alb in the high tertile might have substantial contribution to the benefits of dietary fiber intake on mortality, as shown in our data. In addition, serum CRP levels decreased along with the increased dietary fiber across the tertiles during the whole period. Similarly, the NHANES III study reported that the odds of elevated serum CRP levels decreased by 38% in subjects with CKD for each 10-g/day increase in total fiber intake (11). The ULSAM cohort study also showed that the odds of having CRP >3 mg/L were lower in the quartiles that ate more fiber (10). The causes underlying the relationship between dietary fiber and inflammation have been explored recently. A high-fiber diet could alter gut bacterial metabolism, and decrease the generation and absorption of some toxins that trigger systemic inflammation (24) . A high-fiber diet also has been proposed to be associated with a lower glycemic load of rapidly digestible and absorbable dietary carbohydrates (25, 26) and higher plasma levels of the anti-inflammatory protein adiponectin (27) . Also, fibers may provide a number of health benefits on the kidney by selectively stimulating the favorable growth or activity of a limited number of indigenous bacteria to alter the composition of the intestinal flora and promote toxin discharge, improving the lipid metabolism (28) . Since dietary fiber could exert multifactorial effects for CKD and PD patients, we should draw more attention to observe the potential benefits of increasing fiber intake via dietary or supplements in this population.
Previous studies in the general population suggested that dietary fiber is predictive of lower blood pressure (29) , which might be due to the improved postprandial glucose excursions, insulin resistance (30) , and endothelial dysfunction (31) . Our data indicated a positive association of fiber intake and DBP at baseline and during follow-up. This paradoxical phenomenon might be explained as follows. Our subjects in the high tertile of fiber group had a significantly higher nutrient intake. We cannot exclude the possibility that other nutrients, such as sodium, phosphate and water, exerted harmful effects on blood pressure (32, 33) , offsetting the benefits of dietary fiber. Besides, dietary fiber has many types, such as chitosan, mannans, and pectins, which may exert different effects on the blood pressure (34, 35) , and an overall analysis of total dietary fiber intake cannot determine the effects in detail.
In the present study, the amounts of time-averaged dietary fiber intake were markedly low, i.e., 4.6 g, 6.8 g and 10.1 g in the three tertiles, respectively, which are relatively lower than 10.2 to 12.4 g/d of fiber in HD patients (22, 36) , and 19.8 g/d of fiber in non-dialyzed patients with CKD (37). All above fiber intake levels among CKD patients are lower than the target for healthy individuals (38) (39) (40) . Indeed, patients in the late stage of CKD were requested to decrease dietary potassium, phosphate, and fluid intake with the loss of renal function. Their dietary pattern may lead to a simultaneous reduction of dietary fiber due to the restriction on vegetables, fruit, and nuts. Unfortunately, current guidelines provide inconsistent references for dietary fiber intake for CKD patients (41) . The KDIGO Clinical Practice Guidelines, ESPEN guidelines, and KHA-CARI guidelines emphasize the inclusion of fiber-rich foods in the diet or a balanced diet, rich in fruit and vegetables, but do not recommend an exact amount for fiber (14) (15) (16) . The KDOQI Guidelines on dyslipidemia recommend 20-30 g/day of fiber (42) . In view of limited data in the field, it is necessary to call for robust evidence for the target of dietary fiber in non-dialyzed and dialyzed CKD populations.
The present study had several strengths. To the best of our knowledge, it is the first study to explore whether the baseline and time-averaged fiber intake can predict all-cause mortality in patients on PD. We collected repeat measurements for dietary nutrients rather than a single-point assessment. The patients were thoroughly examined by using time-averaged parameters for their dietary record, biochemical and nutrition data, giving us a unique chance to test our hypothesis. Oral nutrition supplements were also taken into account when evaluating the dietary nutrients. Furthermore, the study was performed in a large PD cohort with a relatively long follow-up and sufficient endpoints. We adjusted for total protein and energy intake when analyzing the correlation between fiber and outcomes to minimize the confounding influences of these nutrients. In spite of those strengths, the results of the present study should be interpreted in caution. First, an observational design cannot allow to establish cause-effect relationship between dietary intake and outcomes such as survival, serum albumin and hsCRP. We cannot exclude that the inverse association of dietary fiber intake and all-cause and CVD mortality is confounded by physical activity or other healthy habits. More biological properties of dietary fiber, including its effect on insulin sensitivity, oxidative stress, inflammation, and protein-bound uremic toxins need to be investigated to explain the observed phenomenon in the dialysis population (43) (44) (45) . Moreover, dietary fiber was not distinguished by soluble and insoluble fiber. Whether different sources and types of fiber exert varied effects on clinical outcome was not determined. Last, this study was conducted in a single center, which limits the generalizability of our data.
Our study revealed that higher dietary fiber intake appeared to have a protective effect on all-cause mortality in non-diabetic PD patients, which suggest that PD patients should be encouraged to eat a diet rich in fibers. Following the observation that PD patients with higher fiber intake concomitantly have better nutrition status and lower inflammation, more potential mechanisms for the benefits of dietary fiber in traditional and non-traditional risk factors need to be explored. Interventional studies are warranted to determine the efficacy and feasibility of fiber intake by dietary or oral supplements in PD patients. Targets for dietary fiber intake should also be determined for patients with CKD.
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